Michael Dickinson

A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma.

R. Johnstone, S. Harrison, J. Seymour, 2011, Blood.

A comparative analysis of histone deacetylase inhibitors for the treatment of mycosis fungoides and Sézary syndrome

R. Twigger, O. Buelens, C. Weyden, 2019, The British journal of dermatology.

Autologous stem cell transplantation for untreated transformed indolent B‐cell lymphoma in first remission: an international, multi‐centre propensity‐score‐matched study

C. Flowers, P. Jain, C. Tam, 2020, British journal of haematology.